- Datum03.04.2025
- Uhrzeit14:30 - 15:00 Uhr
- Veranstalter
XTB
Kein Moderator verfügbar
XBiotech Inc. Aktie
Verkaufen
Kaufen
XBiotech Inc. Chart
XBiotech Inc. Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
3,97 %
Intraday
-3,09 %
1 Woche
-6,27 %
1 Monat
-20,51 %
Seit Jahresbeginn
-62,66 %
1 Jahr
-65,49 %
3 Jahre
-72,67 %
5 Jahre
Wikifolio
Passender Service zu XBiotech Inc.
Webinar zu XBiotech Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)2,940-9,960
- Jahrestief / Hoch ($)2,940-4,670
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von XBiotech Inc.
| Ex-Datum | Fiskaljahr | Dividende | Rendite |
|---|---|---|---|
| 19.02.2020 | - | 23,62 $ | 158,31 % |
| 15.07.2021 | - | 2,47 $ | 13,67 % |
Termine von XBiotech Inc.
Keine aktuellen Termine
Beschreibung
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
